These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27959268)

  • 1. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?
    Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M
    Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
    Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
    Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
    Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
    Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?
    Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M
    Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma.
    Wang L; Li HG; Xia ZS; Wen JM; Lv J
    World J Gastroenterol; 2011 Sep; 17(34):3933-40. PubMed ID: 22025882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer.
    Baltaziak M; Koda M; Wincewicz A; Sulkowska M; Kanczuga-Koda L; Sulkowski S
    Anticancer Res; 2009 Oct; 29(10):4151-6. PubMed ID: 19846965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships between hypoxia-dependent markers: HIF-1alpha, EPO and EPOR in colorectal cancer.
    Baltaziak M; Wincewicz A; Kanczuga-Koda L; Lotowska JM; Koda M; Sulkowska U; Baltaziak M; Podbielski M; Sobaniec-Lotowska ME; Sulkowski S
    Folia Histochem Cytobiol; 2013; 51(4):320-5. PubMed ID: 24497137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma.
    Ribatti D; Poliani PL; Longo V; Mangieri D; Nico B; Vacca A
    Histopathology; 2007 Apr; 50(5):636-41. PubMed ID: 17394500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target.
    Satoh K; Fukumoto Y; Nakano M; Kagaya Y; Shimokawa H
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):570-4. PubMed ID: 21934628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
    Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
    Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.
    Ribatti D; Marzullo A; Gentile A; Longo V; Nico B; Vacca A; Dammacco F
    Histopathology; 2007 Apr; 50(5):591-6. PubMed ID: 17394495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
    Gombos Z; Danihel L; Repiska V; Acs G; Furth E
    Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
    Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
    Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
    Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
    Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G; Xu X; Chu C; Acs P; Verma A
    Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
    Hardee ME; Cao Y; Fu P; Jiang X; Zhao Y; Rabbani ZN; Vujaskovic Z; Dewhirst MW; Arcasoy MO
    PLoS One; 2007 Jun; 2(6):e549. PubMed ID: 17579721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of erythropoietin in regulating angiogenesis.
    Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
    Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.